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Chronic pain is highly prevalent worldwide and imparts a significant socioeconomic and pub-
lic health burden. Factors influencing susceptibility to, and mechanisms of, chronic pain
development, are not fully understood, but sex is thought to play a significant role, and
chronic pain is more prevalent in women than in men. To investigate sex differences in
chronic pain, we carried out a sex-stratified genome-wide association study of Multisite
Chronic Pain (MCP), a derived chronic pain phenotype, in UK Biobank on 178,556 men and
209,093 women, as well as investigating sex-specific genetic correlations with a range of
psychiatric, autoimmune and anthropometric phenotypes and the relationship between sex-
specific polygenic risk scores for MCP and chronic widespread pain. We also assessed
whether MCP-associated genes showed expression pattern enrichment across tissues. A
total of 123 SNPs at five independent loci were significantly associated with MCP in men. In
women, a total of 286 genome-wide significant SNPs at ten independent loci were discov-
ered. Meta-analysis of sex-stratified GWAS outputs revealed a further 87 independent asso-
ciated SNPs. Gene-level analyses revealed sex-specific MCP associations, with 31 genes
significantly associated in females, 37 genes associated in males, and a single gene, DCC,
associated in both sexes. We found evidence for sex-specific pleiotropy and risk for MCP
was found to be associated with chronic widespread pain in a sex-differential manner. Male
and female MCP were highly genetically correlated, but at an rg of significantly less than 1
(0.92). All 37 male MCP-associated genes and all but one of 31 female MCP-associated
genes were found to be expressed in the dorsal root ganglion, and there was a degree of
enrichment for expression in sex-specific tissues. Overall, the findings indicate that sex dif-
ferences in chronic pain exist at the SNP, gene and transcript abundance level, and highlight
possible sex-specific pleiotropy for MCP. Results support the proposition of a strong central
nervous-system component to chronic pain in both sexes, additionally highlighting a poten-
tial role for the DRG and nociception.
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Author summary
Chronic pain is a highly prevalent and debilitating condition, which is more common in
women than in men. Sex differences in this condition may be a result of several factors,
including differences between the sexes in genetic variation related to chronic pain and
gene expression differences related to sex. To explore sex differences in chronic pain from
a genetic perspective, we looked for genetic variants associated with chronic pain in men
and women separately in a large general-population cohort, and compared the variants
we identified between the sexes. We assessed the degree of overlap between genetic vari-
ants associated with chronic pain in each sex and those associated with a wide range of
other traits, including major depression, body-mass index and suicidality. We also investi-
gated gene expression patterns across a range of tissues for genes associated with chronic
pain in each sex, in particular examining expression in neural and non-neural human and
mouse tissues and assessing the degree of Dorsal Root Ganglion (DRG) enrichment, an
important peripheral nervous system component involved in chronic pain. This work
contributes to understanding of chronic pain as a trait and of sex differences in chronic
pain at the levels of genetics and gene expression.
Introduction
Chronic pain is widely defined as pain persisting beyond 3 months [1,2], and can be a primary
disorder [3] or secondarily associated with injury, surgery or a range of medical conditions.
Chronic pain is highly prevalent worldwide [4–9] and imparts a significant socioeconomic
and public health burden [10]. Factors influencing susceptibility to chronic pain, and the
mechanisms underlying its development and maintenance, are not fully understood.
Several aspects of chronic pain including Chronic Pain Grade [11], severe chronic pain and
low back pain have been studied from a genetic perspective and found to be complex traits.
Heritability estimates vary from ~30–46% in twin, pedigree and factor analysis studies [12–
15], while single nucleotide polymorphism (SNP) heritability has been estimated from
genome-wide association studies (GWAS) to be ~7–10% [16,17].
It is increasingly recognised that sex differences in many complex human traits are biologi-
cally important, with genetic architecture for many traits being to some extent sex-specific [18],
and a ‘sex-aware’ approach to genetic analysis has been widely advocated [19]. Sex as a biological
variable has wide-ranging effects on the functioning of the genome and on resultant phenotypes.
These effects can be mediated via sex-differential gene expression [20,21], sex differences in
methylation [22–26] and expression quantitative trait locus (eQTL) effects [27,28], or differing
levels and actions of hormones [29,30]. Sex can also influence traits through environmental fac-
tors strongly correlated with sex [23,24] and sex-specific pleiotropy [25,31]. Chronic pain exhibits
sex-related prevalence differences, and is more common in women than in men [32–34]. There
are also potential sex differences in the impact of pain on functioning in daily life, and in the suc-
cess of specific coping strategies [35]. In addition to differences in prevalence between the sexes,
sex differences in underlying pain mechanisms and their modulation by immune cells have been
recently reported [36–38], and immune responses in general can differ by sex [39].
Multisite Chronic Pain (MCP) is a derived chronic pain phenotype, defined as the sum of
the number of sites of chronic pain on the body, here expressed on a scale from 0–7 [17]. We
have previously shown in UK Biobank [17] that genetic predisposition to MCP (as captured by
a polygenic risk score; PRS) was associated with Chronic Widespread Pain (CWP), a separate
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but related chronic pain phenotype, in women but not men [17]. Additional unpublished find-
ings using the Generation Scotland study [40] demonstrated that the PRS-MCP was associated
with both chronic pain grade and an MCP-like phenotype in both men and women, but that
the magnitude of effect was roughly twice as great in women as it was in men. There was also a
significant PRS-by-sex interaction. These findings suggest that sets of variants contributing to
chronic pain in males and females may act differently, or have different genetic effect sizes, in
the two sexes. Here we report on an exploration of this preliminary evidence for the existence
of sex-specific loci associated with MCP using a sex-stratified GWAS analysis approach in UK
Biobank, and identify several sex-specific MCP loci. A meta-analysis of the female- and male-
specific GWASs also revealed novel MCP loci not identified in the original MCP GWAS. We
have also investigated possible functional effects associated with sex-specific MCP-associated
genes as revealed by gene expression data in multiple relevant tissues, including dorsal root
ganglion (DRG) samples, in both human and mouse.
Results
GWAS of MCP in males and females separately
To detect sex-differential genetic influences on multisite chronic pain, GWASs were run sepa-
rately for males and females in UK Biobank. In men, a total of 123 SNPs at five independent
loci were associated with MCP at a genome-wide significance threshold of p< 5 x 10−8
(Table 1, Fig 1). In women, a total of 286 genome-wide significant SNPs at ten independent
loci were discovered (Table 1, Fig 1). All 15 of these loci were differentially associated with sex
—none of the genome-wide significant SNPs at these loci had p< 5 x 10−8 in the GWAS con-
ducted in the opposite sex. However, a total of 257 SNPs were found to have suggestive levels
of association with MCP (p< 5 x 10−5) in both men and women. Two SNPs had suggestive
evidence in men and were genome-wide significant in women, and eight SNPs had suggestive
evidence in women and were genome-wide significant in men. In addition, the genome-wide
significant loci on chromosome 6 in each sex were separated by less than 1 Mbp and may
potentially exert their influence via differential effects on the same gene.
Table 1. Genome-wide significant independent lead SNPs associated with MCP (p< 5 x 10−8) in male and female sex-stratified GWAS. CHR, chromosome; BP,
chromosome coordinate; A1/A2, alleles 1 and 2, where A1 is the effect allele; BETA/SE, coefficient and its standard error for the effect allele; Gene = ANNOVAR annota-
tion gene symbol for variant (N/A, no gene annotation in ANNOVAR).
SNP rsID CHR BP A1 A2 BETA SE P Sex Gene
rs35072907 1 51189556 G C 0.020 0.004 2.40E-08 Female FAF1
rs59898460 1 150493004 T C 0.025 0.004 4.90E-12 Female LINC00568; RP11-54A4.2
rs147903676 2 5835352 C CT -0.031 0.006 2.00E-08 Female SOX11
rs13135092 4 103198082 A G -0.038 0.006 2.30E-09 Female SLC39A8
rs3080367 5 57576558 TACAC T 0.024 0.004 2.90E-08 Female PGAM1P1; PLK2
rs62381120 5 120176330 T C -0.021 0.004 3.50E-08 Female CTD-2334D19.1; AC008565.1
rs74274428 5 170842428 CA C 0.020 0.004 2.80E-08 Female NPM1; FGF18
rs151060048 6 34633069 CA C -0.035 0.006 5.40E-09 Female C6orf106
rs34003284 13 53902876 C A -0.024 0.004 3.20E-10 Female RN7SL618P; AL450423.1
rs11079993 17 50301552 G T -0.021 0.004 4.50E-09 Female CA10; snoZ178
rs10660361 6 33741371 C CG 0.020 0.004 1.80E-08 Male LEMD2
9:140251458_G_A 9 140251458 G A -0.030 0.005 3.00E-09 Male EXD3
rs16909443 11 6192462 T C -0.040 0.007 4.40E-08 Male RP11-290F24.3
18:50442591_TTTC_T 18 50442591 TTTC T -0.020 0.004 1.60E-08 Male N/A
20:19709268_AAAAT_A 20 19709268 AAAAT A 0.030 0.005 1.20E-08 Male SLC24A3; AL121761.1
https://doi.org/10.1371/journal.pgen.1009428.t001
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LDSR analysis demonstrated that inflation of test statistics in each GWAS was due to poly-
genicity (Table 2; LDSR intercept). SNP heritability was moderate, estimated as 0.125 and
0.106 in females and males, respectively (Table 2). The genetic correlation between male and
female MCP was high (rg = 0.92, SE 0.03; p = 3.32 x 10
−213), but significantly less than 100%
(based on confidence intervals calculated as +/- 2 x SE).
Meta-Analysis of Sex-Stratified MCP GWAS Outputs
87 independent SNPs were found to be associated with MCP at genome-wide significance in
total, 11 of which were novel (not found in the unstratified or in each sex-stratified GWAS
analysis). Each of the 87 independent significant SNPs showed consistent direction of effect
between males and females (Table 3), but seven showed significant heterogeneity in effect size
(I2 p< 0.05). In total, 49 lead SNPs across 46 genomic risk loci were found to be associated
with MCP in meta-analysis of sex-stratified outputs.
Genetic correlations between sex-stratified MCP and other disorders and
traits
A range of complex trait phenotypes were selected for LDSR analysis with male and female
MCP based on previous evidence for phenotypic correlation [17], with the addition of newly
available trait data such as GWAS outputs on suicide and self-harm [41] and mood instability
[42]. Suicidality and self-harm are important comorbidities of chronic pain, an issue
Fig 1. Manhattan plots for the stratified GWAS analyses. Upper panel: female, lower panel: male. Red dotted line
indicates genome-wide significant p-value threshold.
https://doi.org/10.1371/journal.pgen.1009428.g001
Table 2. Trait genetic attributes from the male and female MCP GWASs. SNP-heritability, BOLT-LMM pseudo-
heritability estimate; λGC1000, λGC value adjusted for sample size; LDSR_intercept (SE), LD-score regression intercept




LDSR_intercept (SE) 1.03 (0.006) 1.025 (0.005)
https://doi.org/10.1371/journal.pgen.1009428.t002
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Table 3. Independent, genome-wide significant (GWS) SNPs from meta-analysis of sex-stratified MCP GWASs. Genomic Locus = genomic risk locus context of SNP
with multiple independent GWS SNPs present at some of the 46 loci, rsID = SNP rsID identifier, Position = genomic position (chromosome: base-pair start position),
Meta p = p value for association from the GWAS meta-analysis, Direction = direction of effect in female MCP and male MCP GWASs, respectively (+ if association beta
value for effect allele> 0,—if< 0), I2 = effect size heterogeneity estimate, I2 p = p value for heterogeneity estimate, Symbol = ANNOVAR gene annotation for variant (N/
A, no gene annotation in ANNOVAR). Significant (unadjusted) heterogeneity I2 p values (I2 p< 0.05) are marked with �.
rsID Genomic Locus Position Meta p Direction I2 I2 p Symbol
rs909001 1 1:32196647 2.80E-08 – 7.6 0.298 BAI2
1:51042504_CT_C 2 1:51042504 2.35E-08 – 59.1 0.118 FAF1
rs197441 3 1:112283655 4.33E-10 – 0 0.644 FAM212B-AS1
rs12033257 3 1:112318484 2.79E-08 ++ 0 0.824 KCND3
rs509345 4 1:150276022 1.42E-10 – 71.3 0.062 MRPS21
rs367563576 4 1:150495378 2.24E-11 ++ 89.6 0.002� LINC00568; RP11-54A4.2
rs9700909 5 1:243255124 4.07E-09 – 30 0.232 RP11-261C10.3
1:243461350_CT_C 5 1:243461350 9.48E-09 – 53 0.145 SDCCAG8
rs6721975 6 2:5832667 2.86E-08 – 67 0.082 SOX11
rs4852567 7 2:80703379 3.51E-08 ++ 25 0.248 CTNNA2
rs5832889 8 2:100503396 2.06E-08 ++ 74.9 0.046� AFF3
rs112908707 9 3:49865628 4.35E-10 – 0 0.866 TRAIP
rs62260755 9 3:49898318 5.36E-09 – 0 0.619 CAMKV
3:50098024_CAA_C 9 3:50098024 4.79E-09 ++ 0 0.75 RBM6
rs13067082 9 3:50221715 3.66E-08 ++ 0 0.534 SEMA3F
rs144433312 10 3:84591507 1.07E-08 ++ 26.7 0.243 AC107025.1; LINC00971
rs62263345 11 3:107252190 5.01E-10 – 0 0.848 BBX
rs28750366 12 3:136361055 3.55E-08 – 0 0.498 STAG1
rs56203712 13 4:25342606 1.37E-11 ++ 0 0.783 ZCCHC4
rs201081507 14 4:102681041 8.93E-09 – 51.9 0.149 BANK1
rs13109404 14 4:102896591 1.17E-09 – 0 0.768 BANK1
rs13135092 14 4:103198082 2.61E-14 – 3.4 0.309 SLC39A8
rs6869446 15 5:65570607 3.23E-08 – 3.4 0.309 snoU13; RP11-305P14.1
rs10076888 16 5:103786487 1.06E-08 ++ 0 0.872 RP11-6N13.1
rs147831713 16 5:103787168 9.96E-09 – 0 0.66 RP11-6N13.1
rs325485 16 5:103995368 3.15E-08 ++ 0 0.576 RP11-6N13.1
rs1976423 16 5:104042643 1.48E-08 – 58.3 0.121 RP11-6N13.1
rs137863733 17 5:160890323 8.13E-10 ++ 23.3 0.254 GABRB2
rs6915136 18 6:33651322 1.09E-08 – 37.2 0.207 ITPR3
rs482786 18 6:33707599 1.51E-09 – 29.8 0.233 IP6K3
6:33709752_CA_C 18 6:33709752 1.08E-08 ++ 0 0.5 IP6K3
rs28651968 18 6:33717424 2.16E-08 ++ 0 0.945 IP6K3; LEMD2
rs17529077 18 6:33793332 1.27E-09 ++ 0 0.997 MLN; LINC01016
rs17600945 18 6:33802263 1.21E-09 ++ 0 0.365 MLN; LINC01016
rs6907508 19 6:34592090 2.81E-08 – 50.3 0.156 C6orf106
rs151060048 19 6:34633069 6.92E-09 – 84.4 0.011� C6orf106
rs142415291 19 6:34755312 9.43E-09 – 81.6 0.020� SNRPC; UHRF1BP1
rs6926377 20 6:145105354 7.17E-09 – 49.6 0.159 UTRN
rs148148187 21 7:3602520 1.29E-08 ++ 0 0.839 SDK1
rs7798894 22 7:21552995 3.44E-08 ++ 17 0.273 SP4
rs6966540 23 7:95727967 1.09E-08 – 0 0.67 DYNC1I1
rs10156143 23 7:95844896 6.43E-09 – 0 0.349 SLC25A13
rs1450833 24 7:113865735 1.16E-08 – 0 0.715 FOXP2
7:113945981_CCACTTATAAATACTGTCCCTTGGGCA_C 24 7:113945981 1.24E-08 ++ 0 0.657 FOXP2
(Continued)
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compounded by the common co-occurrence of mental health traits, such as major depressive
disorder (MDD), with chronic pain, and by the fact that use of certain medication in chronic
pain contributes to increased risk for self-harm, suicidal ideation and suicide attempt [43–48].
Table 3. (Continued)
rsID Genomic Locus Position Meta p Direction I2 I2 p Symbol
rs1527146 24 7:113987281 4.56E-08 ++ 27.4 0.241 FOXP2
7:114058731_CA_C 24 7:114058731 5.08E-10 ++ 23.2 0.254 AC073626.2
rs55671932 25 7:150556803 4.07E-08 ++ 68.2 0.076 AOC1
rs6997840 26 8:141658361 2.97E-08 – 0 0.37 AGO2; PTK2
9:96168164_CT_C 27 9:96168164 1.83E-08 ++ 0 0.87 RNU6-829P; Y_RNA
rs7869969 27 9:96217447 9.87E-10 ++ 0 0.797 FAM120A
rs6478241 28 9:119252629 6.61E-09 ++ 5.6 0.303 ASTN2
9:140247497_A_C 29 9:140247497 5.65E-12 – 0 0.567 EXD3
9:140249861_A_C 29 9:140249861 6.70E-09 ++ 23.9 0.252 EXD3
9:140260266_T_G 29 9:140260266 3.38E-14 – 0 0.571 EXD3
rs2183271 30 10:21957229 4.47E-08 – 4.3 0.307 MLLT10
10:99784552_CCA_C 31 10:99784552 1.05E-08 – 40.4 0.195 CRTAC1
rs11599236 32 10:106454672 3.33E-08 ++ 0 0.351 SORCS3
rs17553733 33 11:16362089 1.70E-10 – 0 0.392 SOX6
rs2118362 33 11:16373083 1.32E-08 – 31.9 0.226 SOX6
rs55670730 34 11:43620008 4.18E-08 – 0 0.925 N/A
rs7303462 35 12:23974911 4.61E-08 – 32.5 0.224 SOX5
rs184483429 36 12:107620106 4.87E-08 ++ 0 0.58 RP11-797M17.1; SETP7
rs2759694 37 13:53695378 3.17E-08 ++ 76.8 0.038� OLFM4; LINC01065
rs67128127 37 13:53889000 7.48E-09 ++ 3.4 0.309 RN7SL618P; AL450423.1
rs1443914 37 13:53917230 4.73E-10 ++ 76.7 0.038� RN7SL618P; AL450423.1
rs7335163 37 13:53989975 7.23E-09 ++ 8.9 0.295 AL450423.1; LINC00558
rs17574479 37 13:54049489 2.97E-09 – 88.3 0.003� AL450423.1; LINC00558
rs34521521 38 14:73832318 4.99E-08 – 0 0.512 NUMB
rs4886649 39 15:75328595 2.25E-08 – 0 0.892 PPCDC
15:75348905_CAACA_C 39 15:75348905 1.62E-08 – 0 0.924 PPCDC
rs2386584 40 15:91539572 6.68E-12 – 0 0.578 PRC1
rs285027 41 16:77100932 9.39E-09 – 0 0.748 CTD-2336H13.2; MON1B
rs11871043 42 17:43172849 1.49E-09 ++ 0 0.945 NMT1
rs967823 43 17:50317276 1.98E-11 – 58.8 0.119 snoZ178; RP11-429O1.1
rs35518690 44 18:42136963 2.15E-08 ++ 41.5 0.191 CTC-782O7.1; RP11-456K23.1
rs2043187 45 18:50394405 3.58E-10 – 0 0.668 DCC
rs72922230 45 18:50394407 4.12E-10 – 29.7 0.233 DCC
rs767443167 45 18:50622162 1.43E-08 – 0 0.469 DCC
rs8089828 45 18:50669725 9.63E-10 ++ 0 0.783 DCC
rs8099145 45 18:50743672 2.15E-12 – 0 0.871 DCC
rs12968428 45 18:50750225 1.77E-09 ++ 0 0.413 DCC
rs17410557 45 18:50776391 1.03E-11 – 0 0.561 DCC
rs773737322 45 18:50846440 9.82E-11 ++ 0 0.529 DCC
rs1367635 45 18:50861409 5.25E-09 – 0 0.659 DCC
rs766498304 45 18:50871256 7.87E-09 – 35.6 0.213 DCC
rs10164055 45 18:50919600 2.53E-08 – 0 0.659 DCC
rs16980973 46 20:19648493 1.51E-10 ++ 0 0.322 SLC24A3
https://doi.org/10.1371/journal.pgen.1009428.t003
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MCP in both men and women was found to be significantly genetically correlated with a
range of traits and disorders, including psychiatric and mood phenotypes such as anhedonia,
mood instability, depressive symptoms, MDD, anxiety, suicidality and subjective wellbeing
(Fig 2, S1 Table). In addition, as expected, genetic correlations between both male and female
MCP and unstratified MCP from our previous analysis [17]were essentially perfect (rg = 1.00,
p< 1 x 10−120 for both sexes). PTSD, schizophrenia, autism spectrum disorder, anorexia ner-
vosa, PGC cross-disorder phenotype and primary biliary cirrhosis were found to be signifi-
cantly correlated with MCP in one sex and not the other. Several phenotypes were found not
to be genetically correlated with MCP in either sex (pfdr > 0.05), including inflammatory
bowel diseases, Parkinson’s disease, bipolar disorder, rheumatoid arthritis, and low relative
amplitude (a circadian rhythmicity-related phenotype).
Fig 2. Genetic correlations (rg) between male (M) and female (F) MCP and multiple traits (rg values with 95% CI
error bars). Phenotypes differentially correlated with MCP between the sexes are plotted in orange.
https://doi.org/10.1371/journal.pgen.1009428.g002
Fig 3. Venn diagram of number of genes found significantly associated with MCP in MAGMA gene-based test
analyses. Sectors: Original = non-sex-stratified MCP GWAS, Meta = meta-analysed female and male GWAS output,
Female = female MCP GWAS, Male = male MCP GWAS.
https://doi.org/10.1371/journal.pgen.1009428.g003
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Gene-level analysis
Genes enriched for variants associated with MCP were identified using a gene-level association
analysis (gene-based test) [49] approach implemented by MAGMA as part of the FUMA suite
that tests 19,012 separate genes. The results are summarised in Fig 3 and S2 Table. In females
and males, 31 and 37 genes, respectively, were found to be significantly (Bonferroni-adjusted
significance criterion: p< 2.63 x 10−6) associated with MCP. The only gene found to be signifi-
cantly associated with both male and female MCP was DCC. 24 out of the 31 genes signifi-
cantly associated with MCP in females in the sex-stratified analyses, and 31 out of the 37 genes
significantly associated in males, were also significantly associated in our previous non-strati-
fied analysis [17]. Six genes were significantly associated with MCP only in females (NCAN,
SPATS2L, TBC1D9, CAMK1D, SOX11, GON4L), while 4 genes were associated only in males
(CENPW, MTCH2, NICN1, DNAJA4). Twenty-four genes were identified as significantly asso-
ciated with MCP only in the meta-analysis of the sex-stratified GWAS outputs (Fig 3 and S3
Table). Nineteen genes found in previous sex-combined GWAS analyses [17] were not found
to be associated with MCP in either sex-stratified GWAS, or in GWAS meta-analysis (Fig 3
and S2 Table).
None of the six and four genes associated with MCP in females and males only respectively
had a mouse orthologue listed in the Pain Genes Database [50], an interactive web browser
listing mouse genes associated with pain-related phenotypes when knocked out. None of the
six and four genes associated with MCP in females and males only respectively had a mouse
ortholog listed in the Pain Genes Database [50], an interactive web browser of pain-related
transgenic knockout studies. Of the twenty-four novel genes found to be associated with MCP
in GWAS meta-analyses and associated downstream analyses, one had an ortholog listed in
the Pain Genes Database (Gnaq)[51].
Gene expression analysis
Tissue-enrichment of MCP-associated gene expression was analysed using FUMA, which
implements a MAGMA gene-property analysis [52] using GTEx [53] gene expression datasets
to determine association between trait-associated genes and expression in a range of bodily
Fig 4. MCP-associated gene expression tissue enrichment analysis. Significant (-log10 p> 3) results in female
analyses and their corresponding tissue results in male analyses are shown for brevity. No significant enrichment for
expression in any tissue was found for MCP-associated genes in males. Dashed line = significance threshold.
ACC_BA24 = anterior cingulate cortex BA24, Caudate_BG = caudate basal ganglia, NAc_BG = Basal ganglia—
Nucleus accumbens region, Putamen_BG = Basal ganglia—putamen region. Full results for all 53 tissues can be found
in S1 and S2 Figs.
https://doi.org/10.1371/journal.pgen.1009428.g004
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tissues. MCP-associated genes in females were found to be enriched for expression in the
brain, particularly the cerebellum, and frontal cortex (Fig 4). There was no significant tissue
enrichment for expression of MCP genes found in males (Fig 4).
Fig 5. Mouse cell-type-specific expression patterns for sex-differentiated MCP-associated genes. The mousebrain.
org database was used to identify cell types of expression in the mouse nervous system (brain neurons and glia have
been collapsed to two lines at the base of the plot for clarity) for orthologues of genes identified in this study.
Trinarization score (posterior probability of detection in a particular cell type) was used, rather than expression levels.
The analysis was carried out for 25 genes selected from the male-specific (n = 14) and female-specific (n = 11; note that
Dcc appears in both lists) MCP-associated sets as being enriched for neural tissue expression (neural proportion
score> 0.5, S4 and S5 Tables). While most of these show pan-neuronal expression, a few are expressed in mouse glial
subpopulations (Cdhr4), primarily in CNS neurons (Gabrb2), primarily in DRG neurons (Amigo3), or in limited
subsets of neurons (Dcc, Slc4a10, Camkv).
https://doi.org/10.1371/journal.pgen.1009428.g005
PLOS GENETICS Sex-stratified multisite chronic pain GWAS
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1009428 April 8, 2021 9 / 27
For genes identified (using MAGMA, as reported above) as significantly associated
with MCP in either the male-only or female-only GWAS, we carried out further analyses
of gene expression at tissue and cell-type level by querying existing transcriptomic data-
sets, focusing on neural tissues and tissues specific to each sex. For most tissues GTEx data
were used, but because GTEx does not contain data for dorsal root ganglion (DRG) neu-
rons, which are key for the generation of the nociceptive signals that initiate pain in
chronic pain patients, we assessed expression in this tissue using other comparable data-
sets [54], which additionally contained measures of gene expression enrichment in human
neural tissues (neural proportion score) and in the DRG (DRG enrichment score) (details
in Methods). We also used single cell RNA-seq datasets to estimate whether genes of inter-
est are likely to be expressed in neurons in the peripheral or central nervous systems
(CNS). Full results of this analysis are given in S4 and S5 Tables, while those for a subset of
genes (those enriched for neural tissue expression) are shown in Fig 5. Most of the 37
genes identified from the male-only GWAS were observed to be expressed in the nervous
system. Two of the 37 genes, IP6K3 and FAM129A, had low neural proportion scores, sug-
gesting that they are non-neuronal and non-glial. All 37 genes, however, showed DRG
expression, although expression level was very low for DCC and IP6K3, which were more
highly expressed in the CNS. One gene, AMIGO3, was found to be enriched solely in the
DRG; its orthologue has also been found to be primarily expressed only in mouse DRG
neurons in the www.mousebrain.org dataset (Fig 5). Of the 30 female-specific MCP-asso-
ciated genes, all showed high neural expression except CPS1, which was not expressed in
neural tissue at all. Again, we noted that all 30 genes except GABRB2 (whose mouse ortho-
logue is primarily expressed in CNS neurons, Fig 5) did show expression in DRG (S5
Table), though none of them showed enriched expression in the DRG compared to the
CNS.
Several genes in either the male-only and female-only lists (e.g. CPS1, SEMA3F, MST1,
MST1R, SDK1, ECM1; S4 and S5 Tables) that were expressed in neural tissues but with low
(< 0.5) neural proportion scores were found to be involved in immune function. Among the
genes with high (> 0.5) neural proportion scores, mouse orthologues of many are pan-neuro-
nal in expression based on the mousebrain.org dataset (Fig 5), with a few genes having ubiqui-
tous but neural-enriched expression (Mrps21, Ip6k1), solely glial expression (Cdhr4), or being
expressed in limited neuronal subpopulations including CNS, sensory and enteric neuronal
subtypes (Dcc, Camkv, Slc4a10 respectively). Several of the neuronally expressed genes are
known to be involved in axon pathfinding and neurite outgrowth. Many of these genes have
elevated expression levels in sex-specific tissues like testis and ovary, and / or are somewhat
differentially expressed (10% or more difference in median TPMs across sexes) between male
and female cohorts in brain sub-regions in the GTEx database (S4 and S5 Tables), suggesting
they may be androgen- or estrogen-regulated.
Pathway analyses
No significant results were found for male MCP-associated genes using FUMA GENE2FUNC
[55]. There was no overrepresentation of male MCP-associated genes within any of the Molec-
ular Signatures Database (MSigDB) gene sets (h, c1-c7) [56–58]. Two of the male MCP-associ-
ated genes were associated with disease-related entries in OMIM (Online Mendelian
Inheritance in Man) [59], neither of which mention a pain-related phenotype, and none of the
genes were listed as previously identified drug targets in DrugBank [60] (S6 Table). Amongst
the female MCP-associated genes, overrepresentation was only found for two of the positional
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gene sets listed in MsigDB (S3 Fig). Nineteen female MCP genes were associated with an
OMIM entry, and five were listed as drug targets in DrugBank (S7 Table).
Polygenic risk score analysis
Polygenic risk scores were used to assess whether MCP and chronic widespread pain (CWP), a
related but distinct chronic pain phenotype, are likely to be related biologically. For both men
and women, the sex-specific PRS-MCP was significantly associated with CWP (p< 2 x 10−17;
O.R. = 1.0034 (female) and 1.0026 (male); S8 and S9 Tables), indicating that increased genetic
risk for MCP is significantly associated with having chronic widespread pain.
Discussion
Comparing male and female multisite chronic pain
Prevalence, coping strategies, and, potentially, mechanisms of development and maintenance
of chronic pain vary between the sexes. To explore underlying genetic differences that may
contribute to these sex differences in chronic pain, we carried out a large-scale sex-stratified
GWAS of a quantitative chronic pain phenotype, MCP. We found both male and female MCP
to be moderately heritable. Although the estimated female SNP heritability was higher than
that in males (12.5% versus 10.6% respectively), this difference was not significant.
MCP-associated SNP loci
Twice as many genomic risk loci were identified in GWAS analyses in females as in males (10
versus 5 respectively), with no risk loci shared between the sexes. This may be due to lower
sample size in the male MCP GWAS, both in comparison to previous non-stratified analyses
and to sample size in the female MCP GWAS analysis (roughly 30,000 more participants are
included in the female MCP GWAS than in the male GWAS). Loci were found across the
genome (Fig 1 and Table 3) in both males and females, with genomic location varying by sex.
We note also, however, that significant loci were found in both men and women on chromo-
some 6, only 0.89 Mbp apart (Table 3).
Additional trait-associated SNPs were discovered when the sex-stratified GWAS outputs
were meta-analysed, likely due to increased power. Twenty-four loci that had not reached
genome-wide significance in our previous sex-combined analysis were found to be associated
with MCP after meta-analysis. The fact that these loci were not identified in the non-stratified
GWAS could be due to effect heterogeneity, in terms either of direction or magnitude, between
the sexes reducing the overall signal at these loci.
Previous studies have highlighted sex-specific or sex-differentiated loci in a range of disor-
ders and traits, such as ASD, anthropometric traits and asthma [31,61–63]. Four of the loci
found to be associated with MCP in our meta-analysis of sex-stratified GWAS outputs, includ-
ing 7 SNPs in total, showed signs of heterogeneity of effect size between the sexes (I2 p < 0.05),
though the evidence was not significant after FDR-adjustment. Nevertheless, if these results
are replicated in future studies, it may be that these loci are found to contribute to sex differ-
ences in chronic pain.
Genes of interest
Genes associated with MCP in males. The sex-stratified gene-level analysis discovered a
number of genes with significant evidence for a genetic contribution to MCP. Significant
genes in males included CENPW, MTCH2, NICN1, AMIGO3, DNAJA4, CTBP2 and NOP14,
with the latter two also being significant in the meta-analysis gene-level testing (S2 and S3
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Tables). CENPW encodes centromere protein W, involved in kinetochore assembly and func-
tion, and associated with diseases such as type 1 diabetes [64–66]. MTCH2 (mitochondrial car-
rier 2) encodes a member of the SLC25 family, a family of transporters localised to the inner
membrane of mitochondria and involved in a wide range of cell metabolism functions [67].
SNPs in this locus have previously been associated with obesity [68–70], and this gene may be
involved in regulation of development of adipocytes. NICN1 (nicolin 1) encodes a nuclear pro-
tein of unknown function expressed in a variety of tissues [71]. AMIGO3 (adhesion molecule
with Ig-like domain 3), the only male-specific MCP-associated gene whose expression was
enriched in DRG, is a member of a small family of cell-surface immunoglobulin domain- and
leucine-rich repeat-containing adhesion molecules. Its function is not well understood, but it
is expressed in a range of DRG neuronal subtypes and may play a specialized role in nocicep-
tion or other sensory modalities. Interestingly, AMIGO3 is located almost next to and within
40 kbp of IP6K1, which was also found to be associated in the male gene-level analysis (S2
Table). It may be that there is coordinate regulation of these two genes in tissues relevant to
MCP, or that a number of separate functional variants are distributed across this genomic
locus but in fact only influence expression of one of these two genes. DNAJA4 (DnaJ Heat
Shock Protein Family (Hsp40) Member A4) encodes a heat shock protein [72] previously
shown to be involved in melanoma metastasis and angiogenesis regulation, but is generally
poorly characterised [73].
Genes associated with MCP in females. Genes found to be associated with MCP in
females included NCAN, SPATS2L, TBC1D9, CAMK1D, SOX11, GON4L, and DAGLB, the last
of which was also significantly associated in the meta-analysis. NCAN (neurocan) encodes a
chondroitin sulfate proteoglycan [74] potentially involved in the modulation of cell adhesion
and migration, and previously linked to bipolar disorder in GWAS and mouse model studies
[75,76]. SPATS2L (spermatogenesis associated serine rich 2 like) encodes a protein that may
be involved in ribosome biogenesis and translational control as a response to oxidative cellular
stress [77]. TBC1D9 (TBC1 domain family member 9) encodes a potential GTPase and was
found to be overexpressed in mantle cell lymphoma [78]. TBC1D9 was also recently found to
be involved in a Ca2+-dependent cellular response to infection [79]. CAMK1D (calcium/cal-
modulin dependent protein kinase ID) encodes a member of the calcium/calmodulin-depen-
dent protein kinase 1 family involved in granulocyte regulation, activating CREB-dependent
gene transcription, the activation and differentiation of neutrophils, promotion of basal den-
dritic growth of hippocampal neurons, and apoptosis in erythroleukemia cells [80]. SOX11
(SRY-box transcription factor 11) encodes a member of the SOX (SRY-related HMG-box)
family of transcription factors, with potential roles both in nervous system development and
in neurogenesis during adulthood [81–85]. De novo mutations in this gene have also been
associated with Coffin-Siris syndrome [86]. GON4L (Gon-4 like) encodes a protein involved
in transcriptional repression [87,88]. DAGLB (diacylglycerol lipase beta) encodes an enzyme
that participates in the endocannabinoid synthesis pathway and is required for axonal growth
during development and for retrograde synaptic signalling in mature synapses [89].
Overall, it was notable that genes found to be significantly associated with male and female
MCP were largely different. Only one gene, DCC (DCC netrin 1 receptor; a.k.a. deleted in
colorectal carcinoma), was associated with both male and female MCP. DCC encodes a recep-
tor for the guidance cue netrin 1, and is important for development of the nervous system, par-
ticularly the dopaminergic system [90]. Mutations in the DCC gene have been found in those
with congenital mirror movement disorder (MRMV-1; [91] and it has also been previously
associated with a range of complex brain-related traits, including suicidality, mood instability,
intelligence and putamen volume [41,42,92–94]. DCC has also been highlighted as a risk gene
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for major depression, and may be involved in the pathology of depression through effects on
axon guidance in the developing and adult CNS [95,96].
Gene expression differences in male and female MCP. Gene expression analyses in
GTEx (which does not have DRG samples) carried out using FUMA indicated that expression
of the female-specific MCP-associated genes was enriched primarily in brain tissue, and this
pattern was also seen when meta-analysed sex-stratified GWAS outputs were analysed simi-
larly (not shown). Almost all of these genes were also expressed in the human DRG—it is inter-
esting to speculate as to whether the role of these genes in initiation or maintenance of chronic
pain phenotypes is mediated through roles in the brain or via effects on cells located within the
DRG. No significant enrichment for specific tissues was seen in analyses of male MCP-associ-
ated genes using GTEx and the human DRG expression profiles. The lack of tissue-enrichment
findings for the male-specific genes may, as with the lower number of MCP-associated loci, be
due to reduced power resulting from lower sample size in the male GWAS. However, these
patterns of tissue-level gene expression in GTEx may also indicate differing gene expression
between the sexes, with more ubiquitous expression across all tissues for genes associated with
MCP in males, while genes conferring risk in females may tend to have more tissue-specific
expression patterns. These expression patterns may also be associated with the fact that the
GTEx resource is enriched for male tissue samples (V8 release; 67.1% male)–sex-differential
enrichment of certain genes may be conflated with tissue-differential gene enrichment.
It is still notable that almost all the male or female MCP-associated genes were found to be
expressed in human CNS tissues and in DRG. A subset of these are enriched in human neural
tissues and additionally are expressed in mouse neuronal subpopulations when examining sin-
gle cell sequencing databases (Fig 4). All of these lines of evidence, together, suggest putative
central and peripheral neuronal roles for some of these genes, many of which have not been
historically well studied in the field of chronic pain.
Genetic correlations. For both males and females, MCP was genetically correlated with
non-stratified MCP [17], at rg = 1. In contrast, the genetic correlation between male MCP and
female MCP was found to be high but significantly less than 1 (rg = 0.92), with around 8% of
common SNP-tagged trait variation therefore not shared between the two traits. However, it
could be argued that although this figure suggests that a small subset of genetic variation linked
to MCP is unique to each sex, this difference is not large enough to consider MCP in the two
sexes as biologically distinct to a considerable extent—traits correlated at lower rg are routinely
used as proxies for one another in GWAS settings e.g. educational attainment as proxy for
intelligence (rg ~ 70%) [92], or current age as a proxy for life span (rg ~40–70%) [97].
Genetic correlations with a range of psychiatric disorders, psychological traits and somatic
traits and disorders were explored and notable sex-related commonalities and differences were
observed. Significant genetic correlations of similar magnitude for both sexes were found
between MCP and a range of psychiatric, autoimmune and anthropometric traits. Some phe-
notypes were significantly genetically correlated only with female MCP (schizophrenia, rg =
0.13; PGC cross-disorder phenotype, rg = 0.14; PTSD, rg = 0.44; anorexia nervosa, rg = -0.08),
while others were significantly genetically correlated only with male MCP (autism spectrum
disorder, rg = -0.16; primary biliary cholangitis, rg = 0.14). In most cases, where one sex was
significant and the other was not, the rg values for both sexes were not very different, suggest-
ing that the underlying biology is only subtly, quantitatively different. The sex differences that
were observed may reflect sex-differential patterns of pleiotropy, with some genetic factors
contributing differentially to multiple phenotypes in males and females. It would be of interest
to investigate the relative effect size of loci contributing to MCP and to schizophrenia and
PTSD in the two sexes and the biological mechanisms underlying this difference.
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Observed genetic correlation differences may also, however, be due to differences in sample
size between male and female MCP GWASs (with lower sample size for men compared to
women). Differences may also be a result of either men or women being over-represented in
the comparison GWAS. For example, in the GWAS meta-analysis of autism spectrum disorder
[98] contributing cohorts had M:F ratios from 1.2:1 to as high as 8.6:1, PBC GWASs contribut-
ing to the discovery set in the PBC GWAS meta-analysis [99] contained > 90% female cases,
and the anorexia nervosa GWAS [100] contained only female cases. Analysis of the cohorts
used in the schizophrenia and PTSD GWAS meta-analyses [101–106], suggests that the sex dif-
ference in genetic correlation with MCP for these phenotypes is not primarily driven by an
overrepresentation of one sex.
Comparing the relationship between chronic widespread pain and MCP in
males and females
Each sex-specific PRS was significantly associated with CWP in the corresponding sex, but the
magnitude of association was much lower in comparison to the sex-combined PRS analysis
reported previously [17], which may reflect the smaller sample sizes in the sex-stratified analy-
ses. As previously found in sex combined analyses, results indicated a moderate degree of
shared genetic basis for MCP and chronic widespread pain in both sexes, with degree of shar-
ing potentially slightly stronger in females than in males. It is possible that this difference is
driven at least in part by the overrepresentation of females in CWP cases (M:F ratio 1:1.74).
Clinical perspective on findings and potential impact on treatment
Overall, our findings suggest that MCP shows genetic (and therefore biological) differences
between men and women. If women with MCP are more likely to be at risk of PTSD and
schizophrenia (and vice versa) specific screening for these potential comorbidities could be
appropriate, with a view to instigating additional appropriate management or referrals. Except
for PTSD, however, these sex-differential genetic correlations were relatively small in compari-
son with those that affected both sexes, particularly a range of mood phenotypes. Nevertheless,
the shared biology evident in the significant genetic correlations should stimulate investigation
of whether screening for these potential clinically important co-morbidities can be used to
improve management of chronic pain patients.
Enhanced attention to the sex differences in manifestation and underlying biology of
chronic pain is also merited, and may lead to improvements in clinical assessment, awareness
of risks and choice of medical treatment. For example, if MCP in women is more strongly
associated with immune function (based on evidence from MCP-associated genes), efficacy
and side-effect profiles for drugs targeting immune system function may be different in
women and men. Inappropriate treatments, such as chronic opioid prescribing, might also
have sex-differential consequences—opioids are known to adversely affect immune function
[107,108]. These sex differences in MCP biology may also inform the search for new or re-pur-
posed drugs that can be prescribed in a sex specific manner. It is already known that specific
proteins play sex-specific roles in pain processing and that certain drugs have been found to
have sex-specific analgesic effects (reviewed by [109]).
Limitations
These analyses were carried out using UK Biobank, which was used in our previous sex-com-
bined MCP GWAS [17]. In comparison to our previous analysis, sample size in each individ-
ual sex-stratified GWAS was lower, which leads to somewhat reduced power. However,
sample sizes are still larger than many sex-combined GWAS analyses of chronic pain
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phenotypes, and meta-analysis of the sex-stratified GWAS outputs resulted in an increase in
power to find MCP-associated SNPs overall. True replication is difficult due to heterogeneity
in chronic pain phenotyping and available sample sizes of potential independent cohorts, but
in an independent subset of the UK Biobank, a PRS constructed from each sex-stratified
GWAS output was found to be significantly associated with CWP, a related but distinct
chronic pain phenotype of interest.
Although this work was focused on sex differences in the genetics of MCP we examined
only autosomal variation. An important extension of this work would be to assess genetic asso-
ciations with X chromosome loci, which is likely to provide an additional heritability contribu-
tion and give a fuller picture of sex differences in MCP at the genetic level. Inclusion of the X
chromosome in GWAS analyses is associated with specific methodological and statistical
issues including lower quality genotyping array coverage of the X chromosome compared to
autosomes, differences in how imputation needs to be implemented, differences in X chromo-
some dosage between the sexes leading to differences in population genetics/demographic his-
tory of the X chromosome relative to the autosomes, and changes to quality control required
(and differing QC protocols between sexes) [110,111]. We aim to address this in future work
as we adapt our BOLT-LMM pipeline and downstream analysis pathway.
These GWAS analyses were carried out on a white British subset of UK Biobank, and there-
fore may not generalise to admixed or non-white populations. GTEx donors are also primarily
white (v8 release: 84.6% white, 12.9% African American, 0.2% American Indian, 1.3% Asian,
1.1% Unknown, [https://www.gtexportal.org/home/tissueSummaryPage]), as are donors who
provided DRG tissue (white females [54]), again potentially limiting generalisability of our
findings to non-white populations.
Conclusions
Sex differences in chronic pain likely have, at least in part, a genetic basis and the study of com-
plex traits such as chronic pain is likely to benefit from “sex-aware” analytical approaches. This
study comprises one of the largest sex-stratified genetic analyses of a chronic pain phenotype,
and highlights sex-differential MCP-associated loci, genes, genetic correlations, and patterns
of tissue expression. We also examined transcriptome abundance of key sex-differential MCP-
associated genes in a range of neural and non-neural tissues, including DRG, an important
nervous system component in chronic pain which is not part of the GTEx resource and so
may be understudied in GWASs with follow-up conducted solely using FUMA.
Sex-stratified GWASs can provide an increase in power if heterogeneity in effects of trait-
associated variants is seen between the sexes. Here, 24 novel genes and 11 novel independent
lead SNPs were associated with MCP, in addition to the findings from previous non-sex-strati-
fied work, further contributing to understanding of genetic variation predisposing to chronic
pain.
Genetic correlation results indicated possible sex-differential pleiotropy, including differing
genetic correlations between certain psychiatric disorders and traits and chronic pain in
women compared to men. However, it is of note that genetic correlations between the sexes
are largely similar, particularly with respect to psychiatric disorders and traits including MDD,
anhedonia and depressive symptoms. This is the first study to use novel GWAS outputs from
studies of suicidality and of RDoC mental health traits such as mood instability and anhedonia
in genetic correlation analyses with chronic pain and it provides an important insight into
shared genetic factors between these comorbidities of chronic pain and MCP.
The patterns of gene expression enrichment associated with the identified predisposing
genes supports and enhances our previous conclusion that MCP derives more strongly from
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brain and/or CNS-based mechanisms than from other organ systems and functions. We did
observe, however, that almost all the sex-specific MCP-associated genes identified are
expressed in the DRG as well as in the brain, with one sex differentiated MCP gene, AMIGO3,
being DRG-specific amongst the tissues assessed, raising the possibility that cells in the DRG
that play a specialised role in nociception or other sensory function might be involved in
chronic pain mechanisms. We also observed that several MCP-associated loci in both sexes
have been linked to immune function.
Overall, our findings indicate the existence of potential sex differences in chronic pain at
multiple levels, from SNP-level to transcript abundance and the results support theories of
strong nervous system and immune involvement in chronic pain in both sexes. These findings
may inform development of novel treatment approaches in future, as well as adding to our
understanding of the physiology of chronic pain.
Methods
Chronic pain phenotyping
UK Biobank participants were asked via a touchscreen questionnaire about “pain type(s) expe-
rienced in the last month” (field ID 6159), with possible answers: ‘None of the above’; ‘Prefer
not to answer’; pain at seven different body sites (head, face, neck/shoulder, back, stomach/
abdomen, hip, knee); or ‘all over the body’. The seven individual body-site pain options were
not mutually exclusive, but those who chose ‘all over the body’ could not also select from the
seven individual body sites. Where patients reported recent pain at one or more body sites, or
all over the body, they were additionally asked (category ID 100048) whether this pain had
lasted for 3 months or longer.
Chronic Widespread Pain (CWP) was defined as reported [112], and the ‘case’ group
included only those participants who answered that they had pain ‘all over the body’ that was
longer than 3 months in duration in the touchscreen questionnaire. These individuals were
excluded from analyses of other chronic pain phenotypes as there is some evidence that this
phenotype can be substantially different from more localised chronic pain [113]. Multisite
Chronic Pain (MCP) was a quasi-quantitative variable defined as previously reported [17];
briefly, this variable captures the number of body sites at which chronic pain (at least 3 months
duration) was recorded (excluding those with CWP): phenotypic values therefore ranged from
0 to 7. 10,000 randomly selected individuals reporting no chronic pain were excluded from the
GWAS to use as controls in subsequent polygenic risk score (PRS) analyses.
Genetic quality control
For the GWAS analyses, SNPs with an imputation quality score of less than 0.3, minor allele
frequency (MAF) < 0.01 and/or Hardy-Weinberg equilibrium (HWE) test p< 10−6 were
excluded. Participants whose self-reported sex did not match their genetically-determined sex,
those who had putative sex-chromosome aneuploidy, those considered outliers in UK Biobank
QC in terms of missingness or heterozygosity [114], and those who were not of self-reported
white British ancestry were excluded from analyses. A list of “poor quality” samples (due to
missingness, putative genetic and reported sex mismatch and/or unexpectedly high heterozy-
gosity) was derived by Bycroft et al [114] and is available to all researchers using UK Biobank,
and was used here as part of genetic quality control. Briefly, putative sex chromosome aneu-
ploidy was defined by visual inspection of scatterplots of mean log2 ratio (L2R) on X and Y
chromosomes, and 652 UKB participants meet these criteria for putative sex-chromosome
aneuploidy (Supplemental Information S 3.6 [114]). Samples with a heterozygosity value,
adjusted for both ancestry and genetic principal components (GPCs), above the mean
PLOS GENETICS Sex-stratified multisite chronic pain GWAS
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1009428 April 8, 2021 16 / 27
heterozygosity value (0.1903) and missing rate greater than 0.05 as computed using PLINK ‘—
miss’ command were also flagged as potentially poor quality ([114]; 968 such samples are listed
in this paper’s Supplemental Information S 3.5.3).
A summary of participant MCP phenotypic information for those included in each GWAS
is shown in Table 4.
BOLT-LMM GWAS and gene-level analysis in FUMA
Sex-stratified GWASs of MCP, modelled as a quantitative trait, were carried out using
BOLT-LMM [115], adjusting for age and chip (genotyping array), under the infinitesimal
model of genetic risk, as previously described for our unstratified MCP GWAS [17].
BOLT-LMM uses a genetic relatedness matrix in the model to adjust for population stratifica-
tion and familial relationships. We therefore did not include genetic principal components
(GPCs) in the model. The SNP-level GWAS summary statistics were then analysed using
FUMA [55] to obtain genome-wide plots and carry out MAGMA [49] gene-set and gene-
based test analyses and gene expression analysis using GTEx [53] for male-enriched and
female-enriched MCP genes. Significant independent lead SNPs were determined according
to FUMA. Briefly, FUMA defines lead SNPs as the subset of independent significant SNPs
(SNPs associated with the trait at p< 5 x 10−8 and having LD r2 < 0.6 with any other signifi-
cant SNP) that are not in LD (r2 > 0.1) with any other lead SNP [55]. In addition, when these
LD blocks of independent significant SNPs are in close proximity (< 250kbp apart), separate
loci based on LD thresholds are merged into a single genomic locus, and thus each genomic
risk locus can contain multiple lead and independent significant SNPs [55].
Meta-analysis of male and female GWAS Summary statistics. Meta-analysis of the two
sex-specific GWAS summary statistics datasets was carried out using METAL [116], deploying
a fixed-effects model and weighted by standard error (‘SCHEME STDERR’) with default
options aside from selecting ‘heterogeneity’ in order to analyse heterogeneity (‘ANALYZE
HETEROGENEITY’). A meta-analysis p-value of< 5 x 10−8 was selected as the significance
threshold for association. Gene-level analysis (MAGMA) was also carried out using meta-anal-
ysis output.
Transcriptome analysis of sex-specific association gene lists
We further analysed the tissue and cell type of expression of male-specific and female-specific
genes identified from the MAGMA gene-based analysis of the sex-stratified GWAS results.
Specifically, we characterized gene expression in mammalian nervous system tissues and cell
Table 4. Number of participants per MCP phenotype level group included in each GWAS (male or female sex-
stratified analysis).
MCP N female % female N male % male
0 113148 54.11 105474 59.07
1 49984 23.91 42734 23.93
2 26000 12.43 18612 10.42
3 12376 5.92 7771 4.35
4 5319 2.54 2970 1.66
5 1723 0.82 780 0.44
6 471 0.23 181 0.10
7 72 0.03 34 0.02
total n in each GWAS 209093 NA 178556 NA
https://doi.org/10.1371/journal.pgen.1009428.t004
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types as a potential starting point for identifying the functions of these genes with respect to
pain. We also characterised expression for the one gene found to be associated with both male
and female MCP in the gene-based analyses (DCC).
RNA-seq-derived gene expression values have been previously reported [54] as relative
abundances in TPMs (standardised Transcripts per Million mapped reads) for 12 adult human
tissues (6 neural and 6 non-neural). Additionally, the study notes 3 metrics on a scale of 0 to 1
for each gene based on expression in these 12 tissues: normalized Shannon’s entropy as a mea-
sure of tissue specificity (0 for highly tissue-specific and 1 for tissue-agnostic gene expression
in the quantified tissues), neural proportion score as a measure of enriched expression (possi-
bly neuronal and/or glial) in the nervous system (0 for genes not expressed in the nervous sys-
tem and 1 for genes expressed solely in neural tissues with respect to these 12 tissues), and
DRG enrichment score for identifying specificity of gene expression in the DRG with respect
to the other 11 profiled tissues (0 for no expression in the DRG or for tissue-agnostic gene
expression, and 1 for DRG-specific gene expression in the context of the set of profiled tissues).
The mathematical formulations for these scores are provided in detail in Ray et al. 2018 [54].
The corresponding tables are presented in S4 Table (male) and S5 Table (female).
Genes with neural proportion scores> 0.5 (with overall more neural than non-neural tissue
expression), were further characterized by the putative cell type(s) of gene expression in the
mammalian nervous system (Fig 4). While human single cell resolution RNA-seq datasets are
not publicly available for the peripheral nervous system, a comprehensive database of gene
expression in the mouse nervous system exists: the www.mousebrain.org repository [117].
While it is true that nervous system expression patterns may be different between human and
mouse between nervous system subpopulations due to regulatory evolution or due to differ-
ences in nervous system cell types [118], it is unlikely that expression would change categories
across the 4 broad nervous system cell type categories: neurons, glia, immune and vascular
cells) between human and mouse, given overall conservation of tissue gene expression profiles
across humans and mice [54]. Trinarization scores, defined as the posterior probability (using
a Bayesian framework) of detecting reads from a particular gene in a cell type subpopulation
(details are given in ref. [117]), were used to characterise gene expression by cell-type. Fig 4
visualizes trinarization scores for a range of peripheral nervous system cell types (sensory neu-
rons and glia, enteric neurons and glia, and sympathetic neurons). While peripheral nervous
system vascular and immune cells have not been profiled so far in www.mousebrain.org, we
depict CNS vascular immune cells and vascular cells as surrogate cell types for their PNS coun-
terparts. Both CNS neurons and glia play a critical role in chronic pain, but due to high diver-
sity of cell types were not ideal for summarizing expression patterns in each subpopulation of
these categories succinctly in a single figure. Instead, summary rows for CNS neurons and glia
expression for relevant genes are provided at the bottom of the figure. For further details of
expression in these subtypes, www.mousebrain.org can be queried for mouse gene expression
profiles.
Finally, for genes with neural proportion scores> 0.5, the GTEx database was queried for
sex differential gene expression in profiled CNS regions, and for high expression in sex-specific
tissues, such as testis and ovary, noted in the comments section of S4 and S5 Tables.
Genetic correlations
Genetic correlations with a range of neuropsychiatric disorders and traits were assessed by
LD-score regression (LDSR) for the male and female MCP GWAS outputs separately. Sum-
mary statistics datasets employed were publicly available or available via LD Hub [119,120], or
were results from published and unpublished in-house GWASs. Pre-computed LD scores
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were used, along with HapMap3 SNPs as a reference. By default the munging part of LDSR fil-
ters out SNPs with an info score of< 0.9, a MAF of< 0.01, a GWAS p value outside the range
0–1, strand-ambiguous SNPs, non-SNP (e.g. indel) variants, and SNPs with low sample size.
The default option of no constraint on the LDSR intercept was used. LDSR p-values for genetic
correlation were FDR-corrected within each sex. LDSR was also used to assess trait polygeni-
city and to calculate a SNP-heritability estimate. Note that although some of the GWAS results
used in this analysis came from studies that included UK Biobank data, genetic correlations
estimated using LDSR are not subject to bias caused by sample overlap [121].
Polygenic risk score analysis
Previous analyses showed that a polygenic risk score (PRS) for MCP was associated with the
phenotype of chronic widespread pain (CWP) in women but not in men, and that this PRS
was associated more strongly with chronic pain phenotypes in women than in men in an inde-
pendent cohort (Johnston K.J.A. et al., unpublished). To further explore the relationship
between MCP and CWP, we assessed how separate male and female PRSs for MCP were asso-
ciated with CWP. Separate sex-specific PRSs for MCP, based on the sex-specific GWAS results
reported here, were calculated for a ‘case’ group consisting of participants who reported pain
all over the body that lasted for three months or longer (a proxy phenotype for Chronic Wide-
spread Pain; CWP; N = 6, 813)), and for a ‘control’ group consisting of 10,000 randomly
selected UKB controls, both of which had been excluded from the GWAS analyses (demo-
graphic data for this subsample are given in Table 5).
SNPs associated with MCP at p< 0.01 in the original sex-specific GWAS were selected and
LD-pruned (at a threshold of r2 < 0.1 within a 250kbp window using the PLINK ‘—clump’
command). Sex-specific PRS-MCPs were calculated for each individual in the analysis as the
sum of risk alleles at each SNP, weighted by effect size (beta value) in the GWAS [122]. PRS
values were standardised and z-scores were used in the analysis. Association between stan-
dardised sex-specific PRS-MCP and CWP status was investigated separately in males and in
females in the target case-control subsample using logistic regression, adjusted for chip (geno-
typing array), age and the first eight genetic principal components.
Supporting information
S1 Table. Genetic correlations between MCP and other disorders and traits. Results of
LDSR analysis using summary statistics from the sex-stratified GWASs of MCP versus a range
of potentially related disorders and traits. Genetic correlations are given as rg values (and
FDR-corrected p-values) sorted in order of numerically decreasing rg for female MCP vs other
traits. f_rg and m_rg = genetic correlation value for female and male MCP versus trait, respec-
tively, f_p_fdr and m_p_fdr = FDR-corrected p value for genetic correlation, source = source
of trait GWAS data, PMID = PubMed ID of associated publication for GWAS of trait. Signifi-
cant genetic correlations (FDR-corrected p value < 0.05) within each sex are highlighted
Table 5. Summary of sample sizes of participants used in each of the two PRS analyses (male or female).
Female Male Combined Totals
N mean age (years) N mean age N mean age
Control 5135 56.68 4865 56.96 10000 56.81
CWP 4328 57.00 2485 57.27 6813 57.10
Total 9463 56.83 7350 57.07 16813 56.93
https://doi.org/10.1371/journal.pgen.1009428.t005
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orange, non-significant in blue.
(PDF)
S2 Table. Table accompanying Venn diagram of genes associated with multisite chronic
pain in MAGMA gene-level analyses. ‘Found in’ refers to the GWAS and corresponding
MAGMA gene-level analyses where genes were found to be significantly associated with MCP:
Female = sex-stratified GWAS (female), Male = sex-stratified GWAS (male), Meta = GWAS
meta-analysis of male and female sex-stratified GWAS outputs, Original = sex-combined
GWAS analysis described previously [17]. Total = total number of genes in category.
Elements = gene names.
(PDF)
S3 Table. Genes associated with MCP in MAGMA gene-level analyses of GWAS meta-anal-
ysis output.
(PDF)
S4 Table Expression of genes associated with male MCP in MAGMA analyses across neural
and non-neural tissues TPM = transcripts per million, DRG = dorsal root ganglion
h_DRG_enrich = DRG enrichment score h_entropy = normalized Shannon’s entropy
h_neural_propn = neural proportion score.
(PDF)
S5 Table. Expression of genes associated with female MCP in MAGMA analyses across
neural and non-neural tissues. TPM = transcripts per million, DRG = dorsal root ganglion.
h_DRG_enrich = DRG enrichment score. h_entropy = normalized Shannon’s entropy.
h_neural_propn = neural proportion score.
(PDF)
S6 Table. OMIM and DrugBank derived information (male MCP).
(PDF)
S7 Table. OMIM and DrugBank derived information (female MCP).
(PDF)
S8 Table. Association between male MCP PRS and CWP in men. �Full results (chip, PCs)
not shown for brevity. SE = standard error, Z = Z value, P = p value, OR = odds ratio, PRS = z-
standardised PRS value.
(PDF)
S9 Table. Association between female MCP PRS and CWP in women. �Full results (chip,
PCs) not shown for brevity. SE = standard error, Z = Z value, P = p value, OR = odds ratio,
PRS = z-standardised PRS value.
(PDF)
S1 Fig. Tissue Expression of MCP-associated Genes (male) (53 tissues).
(PDF)
S2 Fig. Tissue Expression of MCP-associated Genes (female) (53 tissues).
(PDF)
S3 Fig. FUMA gene set analysis results for female MCP genes from the gene-level analysis.
(TIFF)
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